Gonadotropin-releasing hormone analogue plus hormone replacement therapy for the treatment of endometriosis: A randomized controlled trial

International Journal of Fertility and Women's Medicine

Volumn 42, Issue 6, 1997, Pages 406-411

  Gregoriou, O ^a   Konidaris, S ^a   Vitoratos, N ^a   Papadias, C ^a   Papoulias, I ^a   Chryssicopoulos, A ^a  

^a UNIVERSITY OF ATHENS   (Greece)

Author keywords

Endometriosis; GnRH a; Hormone replacement therapy

Indexed keywords

CONJUGATED ESTROGEN; DARONDA; ESTRADIOL; FOLLITROPIN; GONADORELIN DERIVATIVE; LEUPRORELIN; LUTEINIZING HORMONE; MEDROXYPROGESTERONE ACETATE; UNCLASSIFIED DRUG;

ADULT; ARTICLE; BONE ATROPHY; BONE DENSITY; BONE MINERAL; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; ENDOMETRIOSIS; FEMALE; HORMONE SUBSTITUTION; HOT FLUSH; HUMAN; INTRAMUSCULAR DRUG ADMINISTRATION; LAPAROSCOPY; LUMBAR SPINE; ORAL DRUG ADMINISTRATION; PELVIS PAIN SYNDROME; PREMENOPAUSE; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SWEATING;

EID: 0031424176     PISSN: 1534892X     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (16)

1. Meldrum DR, Chang RJ, Vale W, et al: Medical oophorectomy using a long-acting GnRH agonist: a possible new approach in the treatment of endometriosis. J Clin Endocrinol 54:1081-1083, 1982.
2. Lemay A, Maheux R, Faure N, et al: Reversible hypogonadism induced by a luteinizing hormone-releasing hormone (LH-RH) agonist (Buserelin) as a new therapeutic approach for endometriosis. Fertil Steril 41:863-871, 1984.
3. Rock JA, Truglia JA, Caplan RJ and the Zoladex Endometriosis Study Group: Zoladex (goserelin acetate implant) in the treatment of endometriosis: a randomized comparison with danazol. Obstet Gynecol 82:198-204, 1993.
4. Comite F: GnRH analogs and- safety. Obstet Gynecol Surv 44:319-325, 1989.
5. The American Fertility Society: Revised American Fertility Society Classification of Endometriosis: 1985. Fertil Steril 43:351-352, 1985.
6. Doberl A, Bergqvist A, Jeppsson S, et al: Regression of endometriosis following shorter treatment with, or lower dose of, danazol. Acta Obstet Gynecol Scand (Suppl) 123:51-58, 1984.
7. Surrey ES: Steroidal and nonsteroidal "add-back" therapy: extending safety and efficacy of gonadotropin-releasing hormone agonists in the gynecologic patients. Fertil Steril 64:673-685, 1995.
8. Maouris P, Dowsett M, Rose G, et al: A new treatment for endometriosis. Lancet II: 1018, 1989.
9. Cedars M, Lu J, Meldrum D, et al: Treatment of endometriosis with a long-acting gonadotropin-releasing hormone agonist plus medroxyprogesterone acetate. Obstet Gynecol 75:641-645, 1990.
10. Friedman AJ, Hornstein MD: Gonadotropin-releasing hormone agonist plus estrogen-progestin "add-back" therapy for endometriosis-related pelvic pain. Fertil Steril 60:236-241, 1993.
11. Sugimoto AK, Hodsman AB, Nisker JA: Long-term gonadotropin-releasing hormone agonist with standard postmenopausal estrogen replacement failed to prevent vertebral bone loss in premenopausal women. Feitil Steril 60:672-674, 1993.
12. Surrey ES, Gambone JC, Lu JKH, et al: The effects of combining norethindrone with a gonadotropin-releasing hormone agonist in the treatment of symptomatic endometriosis. Feitil Steril 53:620-626, 1990.
13. Surrey ES, Voigt B, Fournet N, et al: Prolonged gonadotropin-releasing hormone agonist treatment of symptomatic endometriosis: The role of cyclic sodium etidronate and low dose norethindrone "add-back" therapy. Fertil Steril 63:747-755, 1995.
14. Howell R, Edmonds DK, Dowsett M, et al: Gonadotropin-releasing hormone analogue (goserelin) plus hormone replacement therapy for the treatment of endometriosis: a randomized controlled trial. Fertil Steril 64:474-481, 1995.
15. Lindsay PC, Shaw RW, Coelingh Bennink HJ, et al: The effect of add-back treatment with Tibolone (Livial) on patients treated with the gonadotropin-releasing hormone agonist triptorelin (Decapeptyl). Fertil Steril 65:342-348, 1996.
16. Leather AT, Studd JWW, Watson NR, et al: The prevention of bone loss in young women treated with GnRH analogues with "add-back" estrogen therapy. Obstet Gynecol 81:104-107, 1993.